Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291) |
---|
07/01/1998 | EP0850072A1 A method for preparing radiolabeled peptides |
07/01/1998 | CN1186443A Radiolabeled peptides for diagnosis and therapy |
07/01/1998 | CN1038929C Chelants processing ortho ligating functionality and complexes thereof |
06/30/1998 | US5774782 Technetium-99m generator system |
06/30/1998 | US5773579 Comprising a membrane ion and a phosphorylation site; exhibits carbonic anhydrase activity |
06/30/1998 | US5773292 Ablate or kill cancer cells |
06/30/1998 | US5772982 Method of using hyaluronic acid for the detection, location and diagnosis of tumors |
06/30/1998 | US5772981 Thiolation of proteins for radionuclide-based radioimmunodetection and radioimmunotherapy |
06/25/1998 | WO1998027100A1 Radioactive transition metal nitride hetero-complex |
06/24/1998 | EP0594734B1 Hydroxamate and hydrazide derivatives of polyamines and their medical use as chelating agents |
06/24/1998 | EP0166755B2 Diagnostic and contrast agent |
06/23/1998 | US5770581 Gene transcription and ionizing radiation: methods and compositions |
06/23/1998 | US5770180 Bridge-substituted tropanes for methods of imaging and therapy |
06/23/1998 | US5770179 Composition comprising water soluble beta-glucan that binds to leukocytes in vivo, stannous ion |
06/23/1998 | US5770178 Metal chelate forming peptides and use thereof |
06/23/1998 | US5770030 Process for the separation of carrier-free radio-nuclides from target liquids, the use of the process and an arrangement suitable therefor |
06/23/1998 | US5769787 Medical scanning and treatment system and method |
06/23/1998 | CA1339927C Wavelength-specific cytotoxic agents |
06/18/1998 | WO1998014219A3 A method for the reduction of oxygenated compounds of rhenium or technetium |
06/18/1998 | DE19727815C1 Monoclonal antibody specific for CD164 |
06/17/1998 | EP0847530A1 QUANTITATION OF p97 TO DIAGNOSE AND MONITOR ALZHEIMER'S DISEASE |
06/17/1998 | CN1185116A Ternary radiopharmaceutical complexes |
06/16/1998 | US5766947 Useful in the diagnosis and therapy of a variety of immune-related diseases |
06/16/1998 | US5766571 Method of treating human breast cancer by administration of radiolabeled antibody and unsaturated fatty acids |
06/16/1998 | US5766570 Lymphocyte activation antigens and antibodies thereto |
06/11/1998 | WO1998024917A1 Thrombolytic agents with antithrombotic activity |
06/11/1998 | WO1998024788A1 Tropane derivatives and method for their synthesis |
06/11/1998 | WO1998024774A1 Macrocyclic metal complex carboxylic acids, use and method for the production thereof |
06/11/1998 | WO1998024482A2 Use of endothelin conjugates in therapy, new endothelin conjugates, substances containing them, and processes for producing them |
06/11/1998 | WO1998024481A2 A radiolabelled ligand for selective introduction into the nucleus of a cancer cell |
06/11/1998 | WO1998024480A1 Radioiodinated phospholipid ether analogs and methods of using the same |
06/11/1998 | WO1998024362A1 A breath test for the diagnosis of bacterial infection |
06/11/1998 | CA2273946A1 A radiolabelled ligand for selectively introducing an auger electron emitting radionuclide into the nucleus of a cancer cell |
06/10/1998 | EP0846003A1 Methods of diagnostic image analysis using bioconjugates of metal complexes of nitrogen-containing macrocyclic ligands |
06/10/1998 | EP0444130B1 TECHNETIUM-99m COMPLEX FOR EXAMINING THE RENAL FUNCTION |
06/10/1998 | DE19652387A1 Macrocyclische Metallkomplexcarbonsäuren, ihre Verwendung sowie Verfahren zu ihrer Herstellung Macrocyclic metal complex carboxylic acids, their use and processes for their preparation |
06/10/1998 | DE19652374A1 Verwendung von Endothelin-Konjugaten in der Therapie, neue Endothelin-Konjugate, diese enthaltende Mittel, sowie Verfahren zu deren Herstellung Use of endothelin-conjugates in therapy, new endothelin conjugates, compositions comprising them, and to processes for their preparation |
06/09/1998 | US5763582 Derivatives of triterpenoid acids and uses thereof |
06/09/1998 | US5762909 Combining active material with carrier, introducing into blood vessel |
06/09/1998 | US5762907 Frozen radiopharmaceutical formulations |
06/09/1998 | US5762906 Further improvements relating to radiolabelling of proteins |
06/09/1998 | US5762905 Human neutralizing monoclonal antibodies to respiratory syncytial virus |
06/09/1998 | US5762903 Active radionuclide bonded to chitosan which under physiological conditions forms a non migrating gel; therapy for cancer |
06/04/1998 | WO1998023299A2 Radiolabeled dna oligonucleotide, method of preparation and therapeutic uses thereof |
06/04/1998 | WO1998023286A2 Immunoconjugates comprising human monoclonal antibodies or fragments thereof for diagnostic and therapy |
06/04/1998 | WO1998004294A3 Radiolabeled annexins |
06/04/1998 | CA2271689A1 Radiolabeled dna oligonucleotide, method of preparation and therapeutic uses thereof |
06/03/1998 | EP0844891A1 Hyper comb-branched polymer conjugates |
06/03/1998 | EP0844889A1 Methods of diagnostic image analysis using metal complexes of nitrogen-containing macrocyclic ligands |
06/03/1998 | EP0799050A4 Radiolabeled annexin-galactose cluster conjugates |
06/03/1998 | EP0497926B1 Multi-site metal chelating agents |
06/03/1998 | CN1183303A Radioactive chitosan complex and its macroaggregates, and their preparation method |
06/02/1998 | US5759546 Treatment of CD4 T-cell mediated conditions |
06/02/1998 | US5759516 Peptide-metal ion pharmaceutical preparation |
06/02/1998 | US5759515 Polyvalent peptide pharmaceutical applications |
06/02/1998 | US5759514 Composition for delivery of toxic radioisotopes to the cell nucleus and use |
06/02/1998 | US5759513 Apparatus and process for preparing radioisotope-labeled reagent |
05/28/1998 | WO1998022149A1 Method for treating neoplasia using humanized antibodies which bind to antigen a33 |
05/28/1998 | WO1998022140A2 Hybrid compositions for intracellular targeting |
05/28/1998 | CA2272747A1 Hybrid compositions for intracellular targeting |
05/28/1998 | CA2272341A1 Antisense oligonucleotide compositions for selectively killing cancer cells |
05/28/1998 | CA2272093A1 Method for treating neoplasia using humanized antibodies which bind to antigen a33 |
05/27/1998 | EP0843726A1 Opioid antagonists and methods of their use |
05/26/1998 | US5756825 A chelating compound comprises protein conjugation function and a chelate function; the chelating compound is 3-carboxypropyl n-(tris(2-((n-(benzyloxy)amino)carbonyl)ethyl )-methyl)succinamate |
05/26/1998 | US5756723 Metal-mediated cross-coupling with ring-metalated porphyrins |
05/26/1998 | US5756685 Medical diagnosis; therapy |
05/26/1998 | US5756069 Hydrophilic polymer |
05/26/1998 | US5756068 Methods of radioimaging and radiochemotherapy using phenolic thioeter amines and acyl derivatives thereof |
05/26/1998 | US5756067 Long chain fatty acid ester of cholesterol labelled with radioactive carbon is used for testing presence of or propensity for atherosclerosis and coronary artery disease |
05/26/1998 | US5756065 Macrocyclic tetraazacyclododecane conjugates and their use as diagnostic and therapeutic agents |
05/26/1998 | CA2057053C Recombinant alzheimer's amyloid protein |
05/22/1998 | WO1998021236A1 Connective tissue growth factor-3 |
05/22/1998 | WO1998021207A1 (2,3-dihydrobenzofuranyl)-thiazoles as phosphodiesterase inhibitors |
05/22/1998 | WO1998020909A2 Ex-corpore method for treating human blood cells |
05/22/1998 | WO1998015277A3 Cns-penetrant nk-1 receptor antagonists as antidepressant and/or an anti-anxiety agents |
05/22/1998 | WO1998010795A3 Tumor homing molecules, conjugates derived therefrom, and methods of using same |
05/22/1998 | CA2270908A1 Connective tissue growth factor-3 |
05/20/1998 | EP0842668A1 Ex-corpore method for treating human blood cells |
05/20/1998 | EP0842193A1 Somatostatin-analogous cyclic peptides with inhibitory activity on growth hormone |
05/20/1998 | EP0841953A1 Method and apparatus for interstitial radiation of the prostate gland |
05/20/1998 | EP0841951A2 Compounds with chelation affinity and selectivity for first transition series elements, and their use in medical therapy and diagnosis |
05/20/1998 | EP0841949A2 Saccharide conjugates |
05/20/1998 | CN1181976A Preparation of radiopharmaceutical |
05/19/1998 | US5753504 Using antibodies for inhibiting lipopolysaccharide binding protein mediated lipopolysaccharide-dependent secretion of tumor necrosis factor from myeloid cells |
05/19/1998 | US5753206 Radiometal-binding analogues of luteinizing hormone releasing hormone |
05/19/1998 | US5753205 Radiolabelled peptide compounds |
05/19/1998 | US5753204 Imaging antigens, polypeptides and binding |
05/14/1998 | WO1998019541A1 Methods and compositions for treating and diagnosing tumors using adenosine receptor activated cells |
05/14/1998 | WO1998009647A3 Cyanidin compositions and therapeutic and diagnostic uses therefor |
05/14/1998 | CA2271203A1 Methods and compositions for treating and diagnosing tumors using adenosine receptor activated cells |
05/13/1998 | CN1038328C Bicyclopolyazamacrocyclophosphonic acids, their complexes and conjugates, for use as contrast agents, and processes for their prepn. |
05/12/1998 | US5750660 Contrast agents; medical diagnosis |
05/12/1998 | US5750499 Antitumor |
05/12/1998 | US5750413 Fluorescent markers for cyclosporins |
05/12/1998 | US5750367 Cardiovascular |
05/12/1998 | US5750089 Halogenated neuroprobe for mapping monoamine reuptake sites |
05/12/1998 | US5750088 Stable hydrazones linked to a peptide moiety as reagents for the preparation of radiopharmaceuticals |
05/07/1998 | WO1998018501A2 Improvements in or relating to diagnostic/therapeutic agents |
05/07/1998 | WO1998018500A2 Improvements in or relating to diagnostic/therapeutic agents |
05/07/1998 | WO1998018499A1 Process for the preparation of radiopharmaceuticals |